| $385M | ||
| $350M | ||
| $215M | ||
| $82M | ||
| $76M | ||
| $62M |
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-related macular degeneration and other retina diseases. Outlook Therapeutics, Inc. has collaboration and license agreements with IPCA Laboratories Limited; Laboratorios Liomont, S.A. de C.V.; BioLexis Pte. Ltd.; and Zhejiang Huahai Pharmaceutical Co., Ltd. The company was formerly known as Oncobiologics, Inc. and changed its name to Outlook Therapeutics, Inc. in November 2018. Outlook Therapeutics, Inc. was incorporated in 2010 and is based in Iselin, New Jersey.
Over the last 12 months, insiders at Outlook Therapeutics, Inc. have bought $0 and sold $0 worth of Outlook Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at Outlook Therapeutics, Inc. have bought $8.69M and sold $545,148 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 5,000 shares for transaction amount of $28,446 was made by KENYON LAWRENCE A (Chief Financial Officer) on 2024‑09‑26.
| 2024-09-26 | KENYON LAWRENCE A | Chief Financial Officer | 5,000 0.0216% | $5.69 | $28,446 | -68.75% | ||
| 2024-04-15 | Syntone Ventures LLC | 10 percent owner | 714,286 2.6874% | $7.00 | $5M | -35.27% | ||
| 2024-03-28 | Haddadin Yezan Munther | director | 1,881.71 0.0143% | $11.82 | $22,242 | -49.58% | ||
| 2024-03-07 | Evanson Jeff | CHIEF COMMERCIAL OFFICER | 62,484 0.0245% | $0.42 | $26,243 | -17.56% | ||
| 2023-04-20 | Sale | Dagnon Terry | Chief Operations Officer | 520,000 0.2181% | $1.14 | $590,200 | -62.27% | |
| 2023-01-20 | Sale | Evanson Jeff | Chief Commercial Officer | 267,000 0.1196% | $1.11 | $296,370 | -0.92% | |
| 2023-01-19 | Sale | Evanson Jeff | Chief Commercial Officer | 103,255 0.0462% | $1.22 | $125,971 | -10.00% | |
| 2023-01-18 | Sale | Evanson Jeff | Chief Commercial Officer | 33,738 0.015% | $1.25 | $42,173 | -12.90% | |
| 2023-01-17 | Sale | Evanson Jeff | Chief Commercial Officer | 27,162 0.0122% | $1.31 | $35,582 | -15.63% | |
| 2022-10-07 | Sukhtian Faisal Ghiath | director | 30,000 0.0135% | $1.29 | $38,700 | -9.92% | ||
| 2022-10-07 | Haddadin Yezan Munther | director | 3,600 0.0016% | $1.27 | $4,572 | -9.92% | ||
| 2022-10-06 | Haddadin Yezan Munther | director | 29,743 0.0134% | $1.29 | $38,368 | -9.52% | ||
| 2022-10-05 | HILZINGER KURT J | director | 15,662 0.0068% | $1.23 | $19,264 | -8.80% | ||
| 2022-10-04 | HILZINGER KURT J | director | 95,541 0.0427% | $1.29 | $123,248 | -10.24% | ||
| 2022-09-29 | HILZINGER KURT J | 88,797 0.0438% | $1.24 | $110,500 | -3.36% | |||
| 2022-06-21 | Dagnon Terry | Chief Operating Officer | 10,000 0.0045% | $1.05 | $10,500 | +8.57% | ||
| 2022-06-21 | TRENARY C RUSSELL III | CEO and President | 19,925 0.0091% | $1.06 | $21,121 | +8.57% | ||
| 2022-03-01 | HILZINGER KURT J | director | 27,708 0.0127% | $1.69 | $46,827 | -30.95% | ||
| 2022-02-28 | HILZINGER KURT J | director | 6,000 0.0027% | $1.60 | $9,600 | -28.83% | ||
| 2022-02-24 | HILZINGER KURT J | director | 41,160 0.0167% | $1.46 | $60,094 | -28.66% |
| Sukhtian Ghiath M. | 27834257 67.6567% | $12.02M | 2 | 0 | +92.17% | |
| Mohan Pankaj | 7064553 17.1718% | $3.05M | 1 | 4 | ||
| Syntone Ventures LLC | 10 percent owner | 1705438 4.1454% | $736,408.13 | 3 | 0 | +28.25% |
| Evanson Jeff | CHIEF COMMERCIAL OFFICER | 808459 1.9651% | $349,092.60 | 2 | 6 | |
| Dagnon Terry | Chief Operations Officer | 653058 1.5874% | $281,990.44 | 3 | 3 | +8.57% |
| HILZINGER KURT J | director | 473117 1.15% | $204,291.92 | 34 | 0 | |
| Griffith Donald J. | director | 144926 0.3523% | $62,579.05 | 0 | 1 | |
| Gangloff Scott A. | SVP, Development & Mfrg | 78573 0.191% | $33,927.82 | 0 | 1 | |
| Sukhtian Faisal Ghiath | director | 68000 0.1653% | $29,362.40 | 4 | 0 | +121.5% |
| Yamashita Elizabeth A. | VP, Regulatory Affairs | 64648 0.1571% | $27,915.01 | 0 | 3 | |
| TRENARY C RUSSELL III | CEO and President | 54925 0.1335% | $23,716.62 | 3 | 0 | +8.57% |
| MCANDREW STEPHEN J | SVP Bus. Strat. & Dev. | 50899 0.1237% | $21,978.19 | 0 | 2 | |
| Bahrt Kenneth | Chief Medical Officer | 47120 0.1145% | $20,346.42 | 1 | 2 | |
| THURMAN RANDY H | director | 11875 0.0289% | $5,127.63 | 2 | 0 | +247.3% |
| KENYON LAWRENCE A | Chief Financial Officer | 5946 0.0145% | $2,567.48 | 3 | 3 | +17.42% |
| Haddadin Yezan Munther | director | 5049 0.0123% | $2,180.03 | 6 | 0 | +115.65% |
$448,545 | 49 | -21.85% | $17.98M | |
$6,204,522 | 45 | 1.91% | $16.51M | |
$6,818,859 | 36 | 47.81% | $22.69M | |
$94,610,184 | 33 | -23.48% | $25.81M | |
$114,619,342 | 20 | -7.41% | $15.01M | |
$49,590 | 16 | -37.31% | $12.59M | |
$74,023,014 | 16 | -23.35% | $24.02M | |
$25,487,383 | 15 | -4.37% | $14.01M | |
Outlook Therapeutics, Inc. (OTLK) | $13,486,672 | 11 | 82.26% | $17.76M |
$70,584,874 | 10 | 3.97% | $25.57M | |
$13,595,542 | 9 | -16.74% | $25.81M | |
$206,317 | 7 | -29.23% | $14.96M | |
$8,731,108 | 7 | 153.66% | $22.27M | |
$10,105,079 | 5 | -26.86% | $16.31M | |
$147,504 | 5 | -36.70% | $18.69M | |
$18,186,879 | 4 | 49.41% | $20.13M | |
$9,828 | 3 | -32.17% | $13.34M | |
$157,740 | 3 | 153.95% | $14.41M | |
$500,000 | 1 | -22.94% | $14.95M |
| Increased Positions | 28 | +51.85% | 3M | +75.25% |
| Decreased Positions | 18 | -33.33% | 313,584 | -7.69% |
| New Positions | 8 | New | 718,702 | New |
| Sold Out Positions | 10 | Sold Out | 123,517 | Sold Out |
| Total Postitions | 64 | +18.52% | 7M | +67.56% |
| Vanguard Group Inc | $886.00 | 2.1% | 1.34M | +91,029 | +7.27% | 2025-09-30 |
| Schonfeld Strategic Advisors Llc | $472.00 | 1.12% | 715,170 | -649,639 | -47.6% | 2025-09-30 |
| Blackrock, Inc. | $244.00 | 0.58% | 369,734 | +29,838 | +8.78% | 2025-09-30 |
| Geode Capital Management, Llc | $202.00 | 0.48% | 306,295 | +40,664 | +15.31% | 2025-09-30 |
| Susquehanna International Group, Llp | $140.00 | 0.33% | 211,421 | +93,652 | +79.52% | 2025-09-30 |
| Millennium Management Llc | $128.00 | 0.3% | 194,583 | -143,988 | -42.53% | 2025-09-30 |
| Commonwealth Equity Services, Llc | $75.00 | 0.18% | 113,151 | +85,000 | +301.94% | 2025-09-30 |
| Bank Of America Corp /De/ | $60.00 | 0.14% | 90,475 | +82,662 | +1,058.01% | 2025-09-30 |
| Simplex Trading, Llc | $59.00 | 0.14% | 89,241 | +89,241 | New | 2025-09-30 |
| State Street Corp | $50.00 | 0.12% | 75,302 | -10,150 | -11.88% | 2025-09-30 |